From the University of Colorado Denver a and Denver Health Medical Center, b Denver, CO BLEEDING IS THE MAJOR CAUSE OF PREVENTABLE DEATH AF-TER TRAUMA. Exacerbation of hemorrhage after severe injury is associated with trauma-induced coagulopathy (TIC). TIC was shown to be present in more than 25% of severely injured patients on arrival to the emergency department 1 and subsequently was documented to occur at the time of ambulance arrival in the field. 2 These studies are consistent in indicating that abnormalities in prothrombin time/international normalized ratio (INR) and partial thromboplastin time, conventional laboratory assays used to identify TIC, are independent predictors of mortality after risk adjustment. 3 In an effort to replete the body with substrate for the coagulation cascade, plasma and platelets are presumptively administered in damage control resuscitation and massive transfusion protocols. [4] [5] [6] [7] [8] Although the mechanisms of TIC are poorly understood, retrospective reviews suggest this early administration of plasma and platelets may lead to improved outcomes and survival [4] [5] [6] [7] [8] ; however, blood components are expensive and have been implicated in the pathogenesis of postinjury acute lung injury. 9 Moreover, the role of presumptive antifibrinolytic therapy, remains controversial. 10, 11 The rapid onset of coagulopathy after severe injury before the confounding effects of resuscitation is well recognized, but the precise mechanisms remain unclear. The cell-based model of hemostasis indicates the complexity of TIC. 12, 13 Activation of protein C (APC) via thrombin binding to endothelial thrombomodulin has been proposed as central in the pathogenesis of TIC. Although APC peptide cleavage inactivation of factors V and VIII is reasonably well established, the role of APC in enhancing fibrinolysis via degradation of plasminogen activator-1 is not clear. Thrombelastography (TEG) offers unique insight into TIC because the viscoelastic profile components represent the relative contributions of the various elements of hemostasis as well as clot dissolution.
Principal components analysis (PCA), used initially in the social sciences, is a statistical approach for variable reduction. Multiple variables are unlikely to be independent of one another, ie, a change in one is likely to be accompanied by a change in another. PCA assists in finding correlations between multiple variables and grouping them into uncorrelated components. In simple terms, PCA consists of an automated, systematic examination of correlations among measured variables, aimed at identifying underlying latent principal components (PC). 14, 15 The first PC is a line with the minimum possible distance from all the data points from several variables and explains the most variance; PC2 is a second line, perpendicular to the first line oriented in such a way as to explain the greatest amount of variation not explained by PC1. The process is repeated, with subsequent individual components explaining lesser variance than the previous ones. The end result is that the original set of N variables is replaced by a smaller group of uncorrelated linear, weighted combinations of the original variables. 14, 15 Recently, Kutcher et al 16 used PCA to analyze the potential mechanistic links in TIC using circulating levels of several coagulation factors. Their findings suggested three basic mechanistic pathways for TIC, but platelet poor plasma studies do not replicate the cell-based model of coagulation. Thus, we hypothesize that a PCA of TEGgenerated components would provide additional information on the independent mechanisms for the various phenotypes of TIC.
METHODS
Trauma patients admitted to the Rocky Mountain Regional Trauma Center at Denver Health Medical Center (DHMC) from September 2010 to October 2013 for whom a massive transfusion protocol was activated were included. Our institution's massive transfusion protocol is activated for systolic blood pressure <90 and one of the following: penetrating torso injury, unstable pelvic fracture, or positive focused assessment with sonography for trauma or heuristic observation of the attending surgeon. DHMC is a statedesignated, Level I trauma center verified by the American College of Surgeons Committee on Trauma. Inclusion criteria were: age older than 18 years, acute trauma sustained within 6 hours upon admission, and TEG values obtained within 6 hours postinjury. Patients with documented liver disease and known inherited defects of coagulation function were excluded.
Rapid TEG values were obtained within the first 6 hours postinjury. The distribution of elapsed time from injury to TEG was as follows: 15% in hour 1 postinjury, 38% in hour 2, 16% in hour 3, 12% in hour 4, 10% in hour 5, and 9% in hour 6. Overall, more than 50% were obtained within 2 hours postinjury, and 70% within 3 hours. The numbers of packed red blood cells (RBCs), fresh-frozen plasma (FFP), cryoprecipitate (CRYO), and platelet (PLT) units were recorded for the first 24 hours.
The TEG curve yields key parameters, each representing a functional component of coagulation. The activated clotting time, or ACT value, is the time to clot initiation and is representative of enzymatic clotting factor activation and initial thrombin generation. The angle is the rate of clot formation, which is governed by the effects of concentration of fibrinogen. K is the interval measured from the TEG-ACT to a fixed level of clot firmness or when the amplitude reaches 20 mm; this reflects thrombin's ability to cleave soluble fibrinogen and, hence, the kinetics of clot build-up. The maximum amplitude, or MA, measures the maximum clot strength, which includes the contributions of platelets and fibrin. LY30 is the amount of clot lysis at 30 minutes after MA and represents fibrinolysis. TEG also produces parameters related to the velocity of clotting, calculated from the first derivative of the TEG tracing. These variables, not typically used for clinical TEG interpretation, include maximum rate of thrombus generation (MRTG), time to maximum rate of thrombus generation (TMRTG), and total thrombus generation (TTG).
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Adverse outcomes included intensive care unitfree days (IFD), ventilator-free days (VFD), and mortality. IFD and VFD were determined according to the method proposed by Schoenfeld and Bernard. 17 Data collection and storage were in compliance with the Health Insurance Portability and Accountability Act regulations and have been approved by our Institutional Review Board.
Statistical analysis. Statistical analyses were performed using SAS for Windows version 9.3 (SAS Institute, Cary, NC). Categorical variables were compared using the v 2 test with Yates correction for continuity or the Fisher exact test when expected cell values were <5. Analysis of variance or t tests were used for continuous variables with normal distributions (with appropriate modification when the assumption of equal variances did not hold) whereas continuous variables without a normal distribution were analyzed using the Kruskal-Wallis or Wilcoxon Tests. Due to multiple comparisons, P < .01 was considered significant. Continuous data were expressed as mean ± standard error of the mean or as median and interquartile range (IQR) and categorical data as percentages. PCA was performed using Proc Factor with Method=prin. Because TEG values are not normally distributed and have disparate variances, values were ranked before including them in the PCA. Components with an eigenvalue greater than 1 were retained, and, within components, variable loadings (equivalent to correlation coefficients, range À1 to +1) >j60j were considered significant. A component score was calculated for each patient using the weights of each of the variables for that particular component and was categorized into high and low scores using the median value.
Transferred versus nontransferred patients. Overall, 24.5% of patients included in the study were transferred from an outside hospital. Transferred and nontransferred patients did not differ regarding demographic characteristics (age: 38 years vs 51 years [32-56], P = .1132; male sex: 69% vs 63%, P = .56) or injury severity (ISS: 37 [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] vs 29 [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] , P = .14). Blunt injuries were more frequent among transferred patients (92% vs 64%, P = .009). No differences in intravenous fluid (IVF) and transfusion rates at 
RESULTS
Of the 98 patients included in this study, 92 (94%) patients had complete data necessary for the PCA. Of these, 67% (n = 66) were male, 70% (n = 69) due to blunt injury mechanisms. The median age was 41 years (IQR 28-55), and median body mass index 26.2 kg/m 2 (IQR 23.5-31.4). The median ISS was 31.5 (IQR 24-43). At the emergency department, median systolic blood pressure was 92 mmHg (IQR 78-114) and median heart rate was 111 beats per minute (IQR 96-130). These patients arrived relatively acidotic with a median pH of 7.20 (IQR 7.09-7.30). Fifty-one percent had an INR within the first 6hours >1.5. The overall mortality rate was 28% (n = 27).
PCA produced three distinguishable components, which accounted for 93% of the variance shown in Table I . Also seen in Table I , variables with significant loading for PC1 included K, angle, MA, MRTG, and TTG. For PC2, ACT and TMRTG were variables with significant loading. For PC3, LY30 was the only significant variable.
Comparing patients with high versus low PC1 scores, we found no difference in age, sex, or mechanism of injury (Table II) . High PC1 scores represented patients with a greater injury severity than patients with low PC1 scores. With regard to components of coagulation, patients with high PC1 scores had lesser platelet counts and fibrinogen levels (P = .0001, P < .0001, respectively). Patients with high PC1 scores also had a greater INR and partial thromboplastin time (P = .0135 and P = .0035, respectively). Overall, patients with high PC1 scores required greater volumes of blood products than patients with low PC1 scores. Specifically, patients with high PC1 scores were given more RBCs, FFP, CRYO, and PLT within the first 6 hours compared with patients with low PC1 scores (P < .0001, P < .0001, P = .0002, P = .0001, respectively). This pattern continued at 12 and 24 hours after injury. Patients with high PC1 scores were more likely to have a greater CRYO: RBC and PLT: RBC ratios at 6 hours (P = .0011, P = .0048, respectively). High PC1 scores were associated with worse VFD and IFD (P = .0015, P = .0022, respectively) and greater mortality, although the latter association was nonsignificant (P = .05).
With the exception of male sex, and heart rate at the emergency department, none of the measured variables showed an association with PC2 scores (Table III) .
The PC 3 score was most loaded by LY30, and all patients with low PC3 scores had an LY30 = 0. Patients with high PC3 scores had lesser blood pressure than patients with low PC3 scores (P = .0074) and required more RBCs than patients with low PC3 score, although this difference did not reach significance (P = .0213; Table IV ).
DISCUSSION
In this study, we examine variables of rapid TEG to seek combinations that reflect coagulation mechanisms. High PC1 scores represent a global depletion hypocoagulable state in which there is increased time to clot, slower incorporation of fibrin, and decreased clot strength, identified by a BMI, Body mass index; CRYO, cryoprecipitate; ED, emergency department; FFP, fresh-frozen plasma; GCS, Glasgow Coma Scale; HR, heart rate; ICU, intensive care unit; IQR, interquartile range; ISS, Injury Severity Score; PC, principal component; PLT, platelet; RBC, red blood cell; SBP, systolic blood pressure.
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Surgery j 2014 delay in fibrinogen conversion by thrombin (K), initiation of fibrin crosslinking (angle), and ultimately, decreased clot strength (MA). K represents initial clot kinetics and thrombin's ability to cleave fibrinogen. The angle represents the speed of strengthening of the clot, influenced by the conversion of fibrinogen to fibrin. The angle is dependent on the functional fibrinogen level and is affected by the rate of thrombus generation and, thus, is related to MRTG. MA represents the platelet integration into the fibrin mesh. The amount of thrombus generated (ie, TTG) is associated with the initiation of clot formation. Overall, this score appears to indicate global coagulation related to the enzymatic and platelet components of hemostasis. Having a high PC1 score indicated greater coagulopathy, and patients with high PC1 scores were more likely to require blood transfusions and have adverse outcomes than patient with low PC1 scores. For PC2, we conjecture that the importance of ACT and TMRTG represents a unique parameter of endogenous anticoagulants, such as APC. Recent studies found TMRTG correlated with thrombin antithrombin levels, indicating that TMRTG may be a marker of thrombin generation. 18 Based on previous studies with TMRTG, 19 we would expect a high PC2 score to be associated with hypocoagulability and worse outcomes. Yet, we found no difference in outcomes or transfusion BMI, Body mass index; CRYO, cryoprecipitate; ED, emergency department; FFP, fresh-frozen plasma; GCS, Glasgow Coma Scale; HR, heart rate; ICU, intensive care unit; IQR, interquartile range; ISS, Injury Severity Score; PC, principal component; PLT, platelet; RBC, red blood cell; SBP, systolic blood pressure.
requirements between high and low PC2 scores. Interestingly, Kutcher et al 16 found a third component in their model that was significant loaded with Factor VIII. PC2 may represent another unique phenotype of TIC, which may be due to signals from the endothelium that contributes to thrombin generation. This finding requires further investigation.
The third PC represents hyperfibrinolysis, based on LY30 as a measure of fibrinolysis. A high PC3 score signifies hyperfibrinolysis. Half of the patients had no evidence of fibrinolysis yet a mortality rate more than 25%. This observation is contrary to the notion that patients with any or hyper fibrinolysis are a greater risk of mortality and supports our previous observation and hypothesis that patients with no evidence of fibrinolysis or fibrinolysis shutdown are associated with organ failure; patients with significant fibrinolysis or hyperfibrinolysis are associated with poor outcomes related to exsanguination. 18 On the contrary, patients with evidence of low fibrinolysis or physiologic fibrinolysis are able to lyse clot to perfuse vital organs without exsanguination.
The role of the platelets in coagulation is reflected in PC1. In our PCA, lesser platelet counts were associated with low PC1 scores and more blood component transfusions, but neither median was within the range that most would consider being thrombocytopenic. [20] [21] [22] [23] [24] [25] Thrombocytopenia is BMI, Body mass index; CRYO, cryoprecipitate; ED, emergency department; FFP, fresh-frozen plasma; GCS, Glasgow Coma Scale; HR, heart rate; ICU, intensive care unit; IQR, interquartile range; ISS, Injury Severity Score; PC, principal component; PLT, platelet; RBC, red blood cell; SBP, systolic blood pressure.
Surgery j 2014 associated with increased mortality, multiple organ failure, and poor clinical outcomes in critically ill patients across various specialties. 20, 21, 23, 25 The mechanism underlying thrombocytopenia is not known. A previous study from our group showed that thrombocytopenia in trauma patients is an independent risk factor for multiple organ failure and mortality. 25 This PCA supports the conclusion that low platelets are associated with more blood component transfusion and mortality.
Our PCA using TEG variables confirms the conclusion of Kutcher et al 16 that global depletion coagulopathy is a separate pathologic manifestation of TIC from hyperfibrinolysis. Similar to Kutcher et al, we observed three independent components of coagulopathy despite using different coagulation variables and instruments. Our study used TEG, which can provide information about the clotting process, from initial thrombin activation to fibrinolysis. We have found that TEG provides the cell-based model of coagulation, broken down into three critical steps (initiation, amplification, and propagation) and have used it to guide resuscitation of severe trauma patients. 26 On the basis of these components, it may be possible to identify groups of patients who share characteristics or phenotypes that can guide therapy.
Collectively, this study and others strongly suggest independent mechanisms driving global depletion coagulopathy versus hyperfibrinolysis. A corollary is that empiric treatment of both may not result in the best outcome. Specifically, our recent clinical study 27 suggests that low grade fibrinolysis is protective in a subgroup of patients. We currently are pursuing proteomics and metabolomics in attempts to discern this better at a signaling level.
Limitations. The small sample of this study limits its findings. PCA generally requires large samples to produce stable components that can be validated in a separate dataset. Another limitation of this study was that we used rapid TEG values obtained during the first 6 hours postinjury. In this population of severely injured trauma patients, several interventions may have occurred within this period. This approach and timing of TEG may have affected the TEG values; however, the median IVFs received before the TEG was performed was 1,625 mL (IQR 500-2,300), the median RBC was 2 units (IQR 0-3), and median FFP was 0 (IQR 0-1). RBCs contain negligible amounts of coagulation factors and platelets and does not correct coagulopathy. 28 Although 25% of the patients were transfers from other regional hospitals, all were admitted to DHMC within 6 hours of injury and did not differ substantially from those who were admittedly primarily to our center. No differences in the proportion of transfers were detected for high and low PC1 and PC2 scores. We observed that a greater percentage of patients with low PC3 scores were transferred compared with the group with high PC3 scores. We suspect that patients who were likely to survive the transfer were more likely to have lower LY30 values. Patients who had high LY30 values (resulting in high PC3 scores) may have had hemodynamic instability and early mortality from exsanguination. As a result, these patients were likely not transferred, which may contribute to our inability to detect differences in outcomes between high and low PC3 scores. Finally, the study was limited to one institution, and the results may not be generalizable to other institutions.
CONCLUSION
TIC is a complex process, whose mechanism is not fully understood. Our PCA suggests primary mechanisms for coagulopathy from depleted factors and platelets are distinct from hyperfibrinolysis and underscore the potential of risk for concurrent presumptive treatment for preserved depletion coagulopathy and possible fibrinolysis. On the basis of these summary variables, we may be able to identify phenotypes of postinjury coagulopathy.
